The Importance of Process in a Large Company

Bob Greene left Bayer in 1996 to head a startup biotech company. He says he was frustrated by the process at large companies, which can have veto power. The new firm's focus on cutting-edge genetics led him to make an "agonizing decision" Green: I went from having a thousand people report to me to having 20.